Clinical Trial Update: Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE) [Phase 3]

View source ↗

Summary

Phase 3 trial of C1 inhibitor (human) for prevention and treatment of breakthrough attacks in Japanese subjects with hereditary angioedema has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• C1 Inhibitor (Human) (C1 esterase inhibitor)

Snippet

Sponsor: Shire | Conditions: Hereditary Angioedema (HAE) | Phase 3 | Status: COMPLETED | Results posted: 2018-12-31